Sg Americas Securities, LLC Bluebird Bio, Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$0.47 - $1.35 $34,866 - $100,149	74,185 Added 152.42%	122,855 $64,000
Q2 2024 Jul 12, 2024	SELL	$0.85 - $1.26 $26,657 - $39,516	-31,362 Reduced 39.19%	48,670 $48,000
Q1 2024 May 06, 2024	BUY	$0.91 - $1.75 $59,796 - $114,992	65,710 Added 458.8%	80,032 $102,000
Q4 2023 Jan 12, 2024	BUY	$1.32 - $4.83 $18,905 - $69,175	14,322 New	14,322 $20,000
Q1 2023 Apr 28, 2023	BUY	$3.14 - $8.22 $57,430 - $150,343	18,290 Added 76.95%	42,060 $134,000
Q4 2022 Feb 02, 2023	BUY	$5.77 - $8.49 $35,427 - $52,128	6,140 Added 34.83%	23,770 $164,000
Q3 2022 Oct 31, 2022	SELL	$3.75 - $7.39 $39,836 - $78,503	-10,623 Reduced 37.6%	17,630 $112,000
Q2 2022 Jul 29, 2022	BUY	$2.94 - $5.23 $47,422 - $84,359	16,130 Added 133.05%	28,253 $117,000
Q1 2022 Apr 29, 2022	SELL	$4.07 - $10.6 $43,483 - $113,250	-10,684 Reduced 46.85%	12,123 $59,000
Q4 2021 Feb 07, 2022	SELL	$8.96 - $16.31 $171,306 - $311,830	-19,119 Reduced 45.6%	22,807 $228,000
Q3 2021 Nov 01, 2021	BUY	$11.24 - $21.0 $61,415 - $114,744	5,464 Added 14.99%	41,926 $801,000
Q2 2021 Aug 12, 2021	BUY	$18.04 - $22.09 $265,675 - $325,319	14,727 Added 67.76%	36,462 $1.17 Million
Q1 2021 May 13, 2021	BUY	$16.59 - $33.89 $360,583 - $736,599	21,735 New	21,735 $655,000
Q4 2020 Feb 04, 2021	SELL	$27.5 - $37.92 $815,485 - $1.12 Million	-29,654 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$34.44 - $43.75 $784,922 - $997,106	22,791 Added 332.09%	29,654 $1.6 Million
Q2 2020 Jul 20, 2020	SELL	$27.12 - $45.97 $528,162 - $895,265	-19,475 Reduced 73.94%	6,863 $419,000
Q1 2020 Apr 30, 2020	BUY	$26.16 - $63.5 $648,427 - $1.57 Million	24,787 Added 1598.13%	26,338 $1.21 Million
Q4 2019 Jan 28, 2020	BUY	$46.96 - $61.67 $9,532 - $12,519	203 Added 15.06%	1,551 $136,000
Q3 2019 Nov 04, 2019	SELL	$59.47 - $93.1 $113,885 - $178,286	-1,915 Reduced 58.69%	1,348 $124,000
Q2 2019 Jul 29, 2019	BUY	$75.84 - $105.21 $146,598 - $203,370	1,933 Added 145.34%	3,263 $415,000
Q1 2019 Apr 29, 2019	SELL	$64.44 - $104.11 $9,408 - $15,200	-146 Reduced 9.89%	1,330 $209,000
Q4 2018 Feb 01, 2019	BUY	$59.1 - $93.26 $531 - $839	9 Added 0.61%	1,476 $146,000
Q3 2018 Nov 06, 2018	BUY	$88.86 - $117.49 $130,357 - $172,357	1,467 New	1,467 $214,000
Q2 2018 Aug 07, 2018	SELL	$99.64 - $127.59 $339,872 - $435,209	-3,411 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$105.8 - $150.94 $360,883 - $514,856	3,411 New	3,411 $582,000
Q4 2017 Jan 24, 2018	SELL	$81.25 - $130.7 $323,537 - $520,447	-3,982 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$57.74 - $91.42 $229,920 - $364,034	3,982	3,982 $547,000

Others Institutions Holding BLUE

# of Institutions

128

Shares Held

62.8M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$120 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$81.2 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$36.3 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$36.2 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$29.8 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $598M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account